Method

Our patented technology uses polarized light and our image processing algorithms to accentuate the size, shape, and location and identify retinal protein deposits seen in brain diseases.

 

AI-assisted differential analysis determines the type of protein deposit, the associated disease, and the degree of severity.

Our technology detects

 

Amyloid Beta

Alpha-Synuclein

TDP-43

Drusen

Retinal Blood Vessel Health